These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 16741881)

  • 1. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition.
    Wald A; Krantz E; Selke S; Lairson E; Morrow RA; Zeh J
    J Infect Dis; 2006 Jul; 194(1):42-52. PubMed ID: 16741881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of genital herpes infections.
    Mertz GJ
    Infect Dis Clin North Am; 1993 Dec; 7(4):825-39. PubMed ID: 8106731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for herpes simplex virus transmission to pregnant women: a couples study.
    Gardella C; Brown Z; Wald A; Selke S; Zeh J; Morrow RA; Corey L
    Am J Obstet Gynecol; 2005 Dec; 193(6):1891-9. PubMed ID: 16325589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre.
    Bassett I; Donovan B; Bodsworth NJ; Field PR; Ho DW; Jeansson S; Cunningham AL
    Med J Aust; 1994 Jun; 160(11):697-700. PubMed ID: 8202004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of genital herpes - recent advances.
    Halioua B; Malkin JE
    Eur J Dermatol; 1999; 9(3):177-84. PubMed ID: 10210781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing patients with genital herpes and their sexual partners.
    Patel R; Rompalo A
    Infect Dis Clin North Am; 2005 Jun; 19(2):427-38, x. PubMed ID: 15963881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes.
    Nieuwenhuis RF; van Doornum GJ; Mulder PG; Neumann HA; van der Meijden WI
    Acta Derm Venereol; 2006; 86(2):129-34. PubMed ID: 16648915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.
    Lafferty WE; Downey L; Celum C; Wald A
    J Infect Dis; 2000 Apr; 181(4):1454-7. PubMed ID: 10762576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 2 transmission: risk factors and virus shedding.
    Wald A
    Herpes; 2004 Aug; 11 Suppl 3():130A-137A. PubMed ID: 15319082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
    Slomka MJ
    Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
    Stanberry LR; Spruance SL; Cunningham AL; Bernstein DI; Mindel A; Sacks S; Tyring S; Aoki FY; Slaoui M; Denis M; Vandepapeliere P; Dubin G;
    N Engl J Med; 2002 Nov; 347(21):1652-61. PubMed ID: 12444179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virologic characteristics of subclinical and symptomatic genital herpes infections.
    Wald A; Zeh J; Selke S; Ashley RL; Corey L
    N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
    Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
    N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L; Ashley R;
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study.
    Brown EL; Wald A; Hughes JP; Morrow RA; Krantz E; Mayer K; Buchbinder S; Koblin B; Celum C
    Am J Epidemiol; 2006 Oct; 164(8):733-41. PubMed ID: 16896053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study.
    Jin F; Prestage GP; Mao L; Kippax SC; Pell CM; Donovan B; Templeton DJ; Taylor J; Mindel A; Kaldor JM; Grulich AE
    J Infect Dis; 2006 Sep; 194(5):561-70. PubMed ID: 16897652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
    Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
    AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.